Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

126.70
Delayed Data
As of Jul 27
 -3.36 / -2.58%
Today’s Change
83.26
Today|||52-Week Range
192.94
-5.79%
Year-to-Date
Juno Therapeutics (JUNO) Q2 Earnings: Surprise in Store?
Jul 27 / Zacks.com - Paid Partner Content
What's in Store for Conatus (CNAT) this Earnings Season?
Jul 26 / Zacks.com - Paid Partner Content
What's in Store for Agios Pharma (AGIO) in Q2 Earnings?
Jul 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close130.06
Today’s open126.88
Day’s range126.20 - 133.66
Volume991,443
Average volume (3 months)1,127,821
Market cap$7.0B
Dividend yield--
Data as of 4:00pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)-27.43%
Earnings growth (this year)-7.90%
Earnings growth (next 5 years)+152.82%
Revenue growth (last year)+14,039.75%
P/E ratioNM
Price/Sales142.97
Price/Book11.41

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-3.37-8.09%
IONSIonis Pharmaceutical...-2.25-4.14%
ALNYAlnylam Pharmaceutic...-1.87-2.29%
VRXValeant Pharmaceutic...-0.64-3.60%
Data as of 4:03pm ET, 07/27/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$2.53
Annual revenue (last year)$44.8M
Annual profit (last year)-$387.5M
Net profit margin-864.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Lonnie Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts